Literature DB >> 1368934

Engineering yeast for high level expression.

R Fleer1.   

Abstract

As a eukaryotic microbe, yeast remains an attractive host for the expression of a large variety of foreign proteins, including viral antigens, enzymes used as food additives and therapeutic agents. Important progress has been made in the understanding of the critical parameters influencing product yield, and a number of novel tools for the genetic engineering of powerful yeast expression systems have been developed. This review focuses on recent findings in foreign gene expression in the yeasts Saccharomyces, Pichia, Hansenula, and Kluyveromyces.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1368934     DOI: 10.1016/0958-1669(92)90076-u

Source DB:  PubMed          Journal:  Curr Opin Biotechnol        ISSN: 0958-1669            Impact factor:   9.740


  5 in total

1.  Expression of the Arxula adeninivorans glucoamylase gene in Kluyveromyces lactis.

Authors:  D M Bui; I Kunze; C Horstmann; T Schmidt; K D Breunig; G Kunze
Journal:  Appl Microbiol Biotechnol       Date:  1996-03       Impact factor: 4.813

2.  Development of high-cell-density fermentation for heterologous interleukin 1 beta production in Kluyveromyces lactis controlled by the PHO5 promoter.

Authors:  K Blondeau; O Boutur; H Boze; G Jung; G Moulin; P Galzy
Journal:  Appl Microbiol Biotechnol       Date:  1994-05       Impact factor: 4.813

3.  Use of the KlADH4 promoter for ethanol-dependent production of recombinant human serum albumin in Kluyveromyces lactis.

Authors:  M Saliola; C Mazzoni; N Solimando; A Crisà; C Falcone; G Jung; R Fleer
Journal:  Appl Environ Microbiol       Date:  1999-01       Impact factor: 4.792

4.  Heterologous protein secretion directed by a repressible acid phosphatase system of Kluyveromyces lactis: characterization of upstream region-activating sequences in the KIPHO5 gene.

Authors:  E Fermiñán; A Domínguez
Journal:  Appl Environ Microbiol       Date:  1998-07       Impact factor: 4.792

5.  Expression of recombinant antibodies.

Authors:  André Frenzel; Michael Hust; Thomas Schirrmann
Journal:  Front Immunol       Date:  2013-07-29       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.